Based on the postulated mechanisms, GLI1 inhibition may lead to the downregulation of its target genes, including stemness-related SOX2 and ABCG2 in lung cancer cells, thus underlying its potential therapeutic interference. This evidence concerns the gene SOX2 and lung carcinoma.